yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34778047-B9FFD95A-BFD5-40F4-9CFC-CF1AA3950CAE
Q34778047-B9FFD95A-BFD5-40F4-9CFC-CF1AA3950CAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34778047-B9FFD95A-BFD5-40F4-9CFC-CF1AA3950CAE
Radiotherapy plus nimotuzumab or placebo in the treatment of high grade glioma patients: results from a randomized, double blind trial.
P2860
Q34778047-B9FFD95A-BFD5-40F4-9CFC-CF1AA3950CAE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34778047-B9FFD95A-BFD5-40F4-9CFC-CF1AA3950CAE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5761bd1be33a046ebadae6dd9525471b8ed920d7
P2860
Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity.